AUTHORS: Stapleton JA; Russell MA; Sutherland G; Feyerabend C
AUTHOR AFFILIATION: Institute of Psychiatry, Tobacco Research Section, National Addiction Centre, London, UK. j.stapleton@iop.bpmf.ac.uk
SOURCE: Psychopharmacology (Berl) 1998 Oct;139(3):288-90
ABSTRACT: A cigarette which heats rather than burns tobacco (Premier) was introduced in 1988, but was unacceptable due to unpleasant taste and low nicotine intake. We examined availability of nicotine from a new version (Eclipse), in the same four subjects as our earlier Premier study. Average blood nicotine boosts of 23.7 and 17.8 ng/ml were obtained from smoking a first and second Eclipse. This substantially exceeds intake from Premier (boost 13 ng/ml) and that obtained by heavy smokers from conventional brands (boost 12-15 ng/ml). Eclipse (or similar product) may be the best option for averting Peto's dire warnings of rising millions of annual smoking deaths in the 2020s, and its potential for large-scale, long-term switching warrants further study.
Comments on this posting?
Click here to post a public comment on the Trash Talk Bulletin Board.
Click here to send a private comment to the Junkman.